Sargaquinoic acid and sargahydroquinoic acid from Sargassum yezoense stimulate adipocyte differentiation through PPARα/γ activation in 3T3-L1 cells

被引:60
作者
Kim, Su-Nam [2 ]
Choi, Hye Young [1 ]
Lee, Woojung [2 ]
Park, Gab Man [1 ]
Shin, Woon Seob [1 ]
Kim, Yong Kee [1 ]
机构
[1] Kwandong Univ, Coll Med, Kangnung 210701, South Korea
[2] KIST Gangneung Inst, Kangnung 210340, South Korea
关键词
PPAR alpha/gamma agonist; Sargaquinoic acid; Sargahydroquinoic acid; Sargassum yezoense;
D O I
10.1016/j.febslet.2008.09.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We screened active compounds from natural marine products able to increase PPAR alpha/gamma transcriptional activity. Sargaquinoic acid (SQA) and sargahydroquinoic acid (SHQA) from Sargassum yezoense were identified as novel PPAR alpha/gamma dual agonists. The binding affinity of SQA with PPAR gamma was higher than that of the specific PPAR gamma agonist troglitazone, leading to an activation of PPAR gamma transcriptional activity. In parallel, treatment of 3T3-L1 cells with SQA and SHQA led to an increase in adipocyte differentiation and increased expression of adipogenic marker genes such as aP2, PPAR gamma, resistin, adiponectin, C/EBP alpha and Glut4. Collectively, our data suggest that SQA and SHQA are novel PPAR alpha/gamma dual agonists and may be beneficial for reducing insulin resistance through regulation of adipogenesis.
引用
收藏
页码:3465 / 3472
页数:8
相关论文
共 21 条
[1]  
Bailey Clifford J, 2007, Diab Vasc Dis Res, V4, P161
[2]   PPAR dual agonists: Are they opening Pandora's box? [J].
Balakumar, Pitchal ;
Rose, Madhankumar ;
Ganti, Subrahmanya S. ;
Krishan, Pawan ;
Singh, Manjeet .
PHARMACOLOGICAL RESEARCH, 2007, 56 (02) :91-98
[3]   Drug discovery from medicinal plants [J].
Balunas, MJ ;
Kinghorn, AD .
LIFE SCIENCES, 2005, 78 (05) :431-441
[4]   Effects of peroxisome proliferator-activated receptor δ on placentation, adiposity, and colorectal cancer [J].
Barak, Y ;
Liao, D ;
He, WM ;
Ong, ES ;
Nelson, MC ;
Olefsky, JM ;
Boland, R ;
Evans, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (01) :303-308
[5]   PPARs and diabetes-associated atherosclerosis [J].
Calkin, A. C. ;
Jandeleit-Dahm, K. A. ;
Sebekova, E. ;
Allen, T. J. ;
Mizrahi, J. ;
Cooper, M. E. ;
Tikellis, C. .
CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (26) :2736-2741
[6]   Hypolipidemic therapy for the metabolic syndrome [J].
Cignarella, Andrea ;
Bellosta, Stefano ;
Corsini, Alberto ;
Bolego, Chiara .
PHARMACOLOGICAL RESEARCH, 2006, 53 (06) :492-500
[7]   The biology of peroxisome proliferator -: Activated receptors -: Relationship with lipid metabolism and insulin sensitivity [J].
Ferré, P .
DIABETES, 2004, 53 :S43-S50
[8]   Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors [J].
Gervois, Philippe ;
Fruchart, Jean-Charles ;
Staels, Bart .
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2007, 3 (02) :145-156
[9]   Peroxisome proliferator-activated receptor α/γ dual Agonists for the treatment of type 2 diabetes [J].
Henke, BR .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (17) :4118-4127
[10]   Sargaquinoic acid and sargachromenol, extracts of Sargassum sagamianum, induce apoptosis in HaCaT cells and mice skin:: Its potentiation of UVB-induced apoptosis [J].
Hur, Seulgi ;
Lee, Hyangkyu ;
Kim, Younghwa ;
Lee, Bong-Ho ;
Shin, Jongheon ;
Kim, Tae-Yoon .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 582 (1-3) :1-11